Both in Pharmaceuticals
Zenas BioPharma vs Agios Pharmaceuticals
Over the past year ZBIO returned −9.0% and AGIO returned −21.8%; their daily moves had a correlation of 0.09.
ZBIO −9.0% AGIO −21.8%Growth of $1, one year, split-adjusted
| Metric | ZBIO | AGIO |
|---|---|---|
| Price | $28.51 | $31.38 |
| Market cap | $1.86B | $1.87B |
| Today | +0.44% | +0.58% |
| 1 month | +5.8% | −1.1% |
| 6 months | +36.8% | +16.3% |
| Year to date | −21.5% | +15.3% |
| 1 year | −9.0% | −21.8% |
| Revenue growth (YoY) | — | +259.3% |
| Gross margin | 100.0% | 93.3% |
| Net margin | −11145.6% | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | 1,857.9× | 19.1× |
| Net cash | $346.1M | $617.6M |
| Dividend yield | — | — |
| Volatility (60d) | 55.9% | 58.0% |
| Short % of float | 40.2% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).